Telemedicine and Cancer Care

Author:

Doshi Sahil D.,Bange Erin M.,Daly Bobby,Kuperman Gilad,Panageas Katherine S.,Morris Michael J.

Abstract

Abstract Telemedicine holds the potential to transform cancer care delivery and optimize value, access, and quality of care. A transformed regulatory environment coupled with the need to continue medical care despite operational limitations led to the rapid expansion of telemedicine in cancer care during the COVID-19 pandemic. Its utilization has since varied, and it has faced significant challenges. In this review, we will explore the state of telemedicine in cancer care delivery, the challenges it faces, and strategies to enhance its successful implementation.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference43 articles.

1. Telemedicine in cancer care beyond the COVID-19 pandemic: oncology 2.0?;Curr Oncol Rep,2022

2. Trends in outpatient care delivery and telemedicine during the COVID-19 pandemic in the US;JAMA Intern Med,2021

3. COVID-19 in patients with lung cancer;Ann Oncol,2020

4. Annual report to the nation on the status of cancer, part 2: patient economic burden associated with cancer care;J Natl Cancer Inst,2021

5. Five years of cancer drug approvals: innovation, efficacy, and costs [published correction appears in JAMA Oncol 2015;1(4):544];JAMA Oncol,2015

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3